Stay updated on Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2. No changes to study data, eligibility criteria, or navigation.
    Difference
    0.0%
    Check dated 2026-02-12T23:07:32.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added and Revision: v3.4.0 was removed, which are minor UI metadata changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T12:19:45.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The page now includes a glossary toggle and minor metadata and wording updates (Last Update Submitted that Met QC Criteria, No FEAR Act Data capitalization, and Revision: v3.4.0) compared with the previous version. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-29T06:29:35.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added a visible 'Last Update Posted' timestamp and removed the 'Last Update Posted (Estimated)' label in the study record. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-22T05:30:28.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    A minor revision update from v3.3.3 to v3.3.4 is shown, with no visible changes to study details or page layout. No user-facing content was altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T03:16:49.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    - Added a dedicated Locations section with New Jersey and New York sites and updated the revision to v3.3.3. - Removed the separate New Jersey Locations and New York Locations entries and the HHS Vulnerability Disclosure link, reflecting the updated structure.
    Difference
    0.3%
    Check dated 2025-12-17T18:55:09.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial page.